Exploration of genes and the functions affected by serum calcium-decreasing factor (caldecrin)
Exploration of genes and the functions affected by serum calcium-decreasing factor (caldecrin)
批准号:
11671852
负责人:
TOMOMURA Akito
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
钙调蛋白是一种胰凝乳蛋白酶型丝氨酸蛋白酶,是我们从胰腺中分离纯化的降钙因子。钙调蛋白以前体形式合成并从细胞分泌。在研究钙调蛋白功能的过程中,我们发现:1)钙调蛋白抑制骨吸收,但不具有蛋白酶活性。对应于大鼠钙调蛋白的氨基酸序列(aa 71 -79)负责钙调蛋白对骨吸收的抑制。2)钙调蛋白在骨骼肌中有表达,其mRNA表达量随肌肉分化的进行而增加。3)钙调蛋白基因在出生后1-28天的大鼠脑中呈组成性表达。结果表明,在大鼠的嗅球、大脑、海马、丘脑和小脑等脑组织中均检测到钙调蛋白mRNA的表达,表明钙调蛋白是一种多功能蛋白酶。
英文摘要
Caldecrin, a serum calcium-decreasing factor that we purified from pancreas, is a chymotrypsin-type serine protease. Caldecrin is synthesized as proform and secreted from the cells. In the course of research project that explore the function of caldecrin, we found the results as follows; 1) caldecrin suppressed bone resorption without its protease activity. The amino acid sequence corresponding to rat caldecrin (aa71-79) is responsible for the suppression of bone resorption by caldecrin. 2) Caldecrin was expressed in the skeletal muscle and its mRNA expression was increased with the progress of muscle differentiation. 3) Caldecrin detected in adult rat brain.The caldecrin gene was constitutively expressed during postnatal days 1-28 in the brain. The caldecrin mRNA was detected in the whole brain, including the olfactory bulb, cerebrum, hippocampus, thalamus and cerebellum.These results indicate that caldecrin is multi-functional protease.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tomomura A., Yamada H., Fujimoto K., Inaba A. and Katoh S.: "Determination of amino acid sequence resp onsible for suppression of bone resorption by serum calcium-decreasing factor(caldecrin)."FEES Letter.. 508. 454-458 (2001)
Tomomura A.、Yamada H.、Fujimoto K.、Inaba A. 和 Katoh S.:“测定血清钙减少因子(降钙蛋白)抑制骨吸收的氨基酸序列。”FEES Letter.. 508。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomomura A., Yamada H Itagaki K., Fujimoto K.Katoh S.: "Rat brain expresses serum calcium-decreasing factor (caldecrin)"Neuroscience Letter. 317. 17-20 (2002)
Tomomura A.、Yamada H Itagaki K.、Fujimoto K.Katoh S.:“大鼠大脑表达血清钙减少因子(钙蛋白)”神经科学快报。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomomura A., Yamada H., Fujimoto K., Inaba A.Katoh S.: "Determination of amino acid sequence responsible for suppression of bone resorption by serum calcium-decreasing factor (caldecrin)"FEBS Letter. 508. 454-458 (2001)
Tomomura A.、Yamada H.、Fujimoto K.、Inaba A.Katoh S.:“血清降钙因子(降钙蛋白)抑制骨吸收的氨基酸序列的测定”FEBS Letter。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomomura A., Yamada H., Itagaki K., Fujimoto K. and Katoh S.: "Rat brain expresses serum calcium-decreasing factor (caldecrin)"Neuroscience Letter. 317. 17-20 (2002)
Tomomura A.、Yamada H.、Itagaki K.、Fujimoto K. 和 Katoh S.:“大鼠脑表达血清钙减少因子(钙蛋白)”神经科学快报。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Inhibitory mechanism of caldecrin on RANKL-stimulated signaling platform formation in the osteoclasts
-
批准号:24592811
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.49万
-
财政年份:2012
-
负责人:TOMOMURA Akito
-
依托单位:
Searches for the molecular pathogenesis of skeretal and neuronal system from serum calcium-decreasing factor, caldecrin, knock out mouse
-
批准号:16591864
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:TOMOMURA Akito
-
依托单位:
Gene therapy with serum calcium-decreasing factor, caldecrin, for osteoporosis
-
批准号:14571773
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2002
-
负责人:TOMOMURA Akito
-
依托单位:
Analysis of Receptor for Bone Resorption Suppressor Caldecrin
-
批准号:09671904
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:TOMOMURA Akito
-
依托单位:
海外基金